Prognostic significance of the chemerin level in coronavirus disease 2019 patients

Author:

Gokdemir Gül Şahika1ORCID,Gokdemir Mehmet Tahir2,Araç Songül3,Yokuş Beran4

Affiliation:

1. Faculty of Medicine, Physiology Department, Mardin Artuklu University, Mardin, Turkey

2. Faculty of Medicine, Emergency Department, Mardin Artuklu University, Mardin, Turkey

3. Emergency Department, University of Health Science, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey

4. Faculty of Veterinary, Biochemistry Department, Dicle University, Diyarbakir, Turkey.

Abstract

Increased serum chemerin levels have been reported in several inflammatory diseases. Few studies have investigated the relationship between chemerin and clinical features of COVID-19. Thus, chemerin may modulate the development and progression of COVID-19. We compared the serum chemerin concentration between patients with and without SARS-CoV-2 infection and its association with the severity and prognosis of COVID-19 pneumonia. This is a prospective, single-center, cross-sectional study. We enrolled COVID-19 patients who presented to our tertiary hospital and healthy controls. The COVID-19 patients were conducted and the dates of symptom onset were recorded. After admission to the hospital and stabilization, blood samples were obtained for routine hemogram, biochemistry, and chemerin. The chemerin level was 37.93 ± 17.3 ng/mL in patients followed in the ICU, 29.41 ± 12.79 ng/mL in inpatients, 30.48 ± 10.86 ng/mL in outpatients, and 25.12 ± 9.82 ng/mL in healthy controls. The difference between patients treated in the ICU and healthy controls was significant (P < .001). The high-sensitivity C-reactive protein (hs-CRP), ferritin, procalcitonin (PCT), and D-dimer levels were significantly higher in the intensive care unit (ICU) group (P < .001). Moreover, the chemerin level of patients who died was significantly higher than that of those who survived (P < .001). The chemerin level was increased in COVID-19 patients and also increased with increasing disease severity. The chemerin level was higher in the COVID-19 patients than healthy controls and was significantly higher in patients who died compared to those who did not.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference22 articles.

1. Developing novel liquid biopsy by selective capture of viral RNA on magnetic beads to detect COVID-19.;Kerachian;Iran J Basic Med Sci,2022

2. One-year follow-up evaluation of radiological and respiratory findings and functional capacity in COVID-19 survivors without comorbidities.;Ogun;Medicine (Baltim),2023

3. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT.;Bai;Radiology,2020

4. Chemerin in inflammatory diseases.;Xin;Clin Chim Acta,2021

5. The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis.;De Palma;Kidney Int,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3